Vor Biopharma (VOR)

• Market cap: $664M
• 1 day: -7%
• 5 days: -0.47%
• 1 month: 11.54%
• 3 months: 22.67%
• 6 months: -59.12%
• Year to date: 27.84%
• 1 year: -16.12%
• 5 years: -98.27%
• 10 years: -98.02%
• Sector: Healthcare
• Industry: Biotechnology

About: Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Employees: 168